ACOART BTK RENEW:A Post Market Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 107 participants.

Also called NCT04885985

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 107 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04885985
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04885985. Allocation not applicable; no masking; primary purpose treatment. Start 2021-12-31 (actual); primary completion 2024-08-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ACOART BTK RENEW:A Post Market Clinical Study
Condition
Peripheral Artery Disease
Intervention (Device)
DEB catheter
Lead sponsor
Acotec Scientific Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct04885985
Content hash
8917be407688bb609acdff5ca8412c0cfb2fd22a7b2d86b5182a3b0bbbbad2c3